News & Updates

Show Multimedia Only

Testosterone recovery after ADT tied to improved OS in prostate cancer

16 Apr 2025 by

Testosterone recovery to a normal level appears predictive of improved overall survival (OS) among men with intermediate-risk prostate cancer who underwent androgen-deprivation therapy (ADT) and radiation therapy (RT), suggests a study.

16 Apr 2025

TB vax primer augments BCG-induced immune response in bladder cancer patients

15 Apr 2025 by

Initial results of the phase I RUTIVAC-1 study show the potential of two doses of a tuberculosis (TB) vaccine given after surgery but before standard BCG* treatment to boost immunity and reduce the odds of recurrence in patients with non-muscle-invasive bladder cancer (NMIBC).

15 Apr 2025

Shockwave therapy plus tadalafil beneficial to Asians with ED

14 Apr 2025 by

In the treatment of mild to moderate erectile dysfunction (ED), low-intensity extracorporeal shockwave therapy combined with tadalafil helps improve outcomes, according to the preliminary results of a study from China.

14 Apr 2025

Original New Drug Application Approvals by US FDA (16-31 March 2025)

10 Apr 2025

New drug applications approved by US FDA as of 16-31 March 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

10 Apr 2025

What’s new in advanced urothelial carcinoma?

02 Apr 2025 by

Enfortumab vedotin and pembrolizumab’s (EV+P) EV-302 trial results represent a major advancement in metastatic urothelial carcinoma (mUC), including in Asian patients, according to Professor Ravindran Kanesvaran of the National Cancer Centre in Singapore, who also discussed managing skin toxicity associated with this regimen and provided an overview of other agents for UC under investigation at Uro-Oncology Asia 2025.

02 Apr 2025

More prostate cancers caught with transperineal vs transrectal biopsy

29 Mar 2025 by

When sampling prostate tissue using ultrasound guidance and local anaesthesia, going by the transperineal (LATP) approach results in greater detection of clinically significant prostate cancers relative to the transrectal (TRUS) approach, as shown in the TRANSLATE trial.

29 Mar 2025

Microultrasonography a promising alternative to MRI for image-guided prostate biopsy

29 Mar 2025

Microultrasonography-guided biopsy performs similarly as MRI/conventional ultrasonography fusion-guided biopsy in terms of detecting Gleason Grade Group 2 or higher prostate cancer in biopsy-naïve men, according to the results of the multicentre, international OPTIMUM study.

29 Mar 2025